Develops vaccines for cancer and infectious diseases.
Dec 2025Revenue $7.53M/yrExpenses $16.8M/yr
No trendCash runway ≈ 3.5 years from Dec 2025
Figures by year
When will Evaxion A/S be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $7.53M and expenses $16.8M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $7.53M | $16.8M | −$9.23M |
| Dec 2024 | $3.34M | $18.1M | −$14.7M |
| Dec 2023 | $73.0K | $22.3M | −$22.2M |
| Dec 2022 | $0.00 | $25.3M | −$25.3M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.